Literature DB >> 7299139

Serum immunoglobulins and lymphocyte subpopulations derangement in Turner's syndrome.

E Cacciari, M Masi, M P Fantini, F Licastro, A Cicognani, P Pirazzoli, M P Villa, F Specchia, A Forabosco, C Franceschi, L Martoni.   

Abstract

Abnormalities of the proportions of peripheral blood lymphocyte subpopulations and of immunoglobulin serum levels were found in twenty patients affected by Turner's syndrome. A slight but significantly decreased percentage of circulating T and B cells, and increased percentage of null cells and a decreased in vitro responsiveness of lymphocytes to phytohaemagglutinin, concanavalin A and pokeweed mitogen were found in Turner's syndrome patients. IgG serum level was found significantly decreased in comparison with age-matched fifty-seven normal males and fifty-seven normal females and IgM serum level was intermediate between female and male values; Turner's syndrome patients with monosomy had an IgM serum concentration very close to male values. The derangement of T and B lymphocyte subpopulations, probably related to the aneuploidy, does not seem to be a severe one but it could account for the immunoglobulin abnormalities and for the association of Turner's syndrome with immunological disorders such as autoimmune diseases. The role of X chromosome on IgM serum level is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299139     DOI: 10.1111/j.1744-313x.1981.tb00938.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  17 in total

1.  Common variable immunodeficiency with CD4+ T lymphocytopenia and overproduction of soluble IL-2 receptor associated with Turner's syndrome and dorsal kyphoscoliosis.

Authors:  R A al-Attas; A H Rahi
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

Review 2.  Sex differences in immune responses.

Authors:  Sabra L Klein; Katie L Flanagan
Journal:  Nat Rev Immunol       Date:  2016-08-22       Impact factor: 53.106

3.  T Follicular Helper Cell-Dependent Clearance of a Persistent Virus Infection Requires T Cell Expression of the Histone Demethylase UTX.

Authors:  Kevin D Cook; Karl B Shpargel; Joshua Starmer; Fatima Whitfield-Larry; Bridget Conley; Denise E Allard; Julia E Rager; Rebecca C Fry; Marsha L Davenport; Terry Magnuson; Jason K Whitmire; Maureen A Su
Journal:  Immunity       Date:  2015-09-29       Impact factor: 31.745

Review 4.  Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma.

Authors:  Nico Buettner; Robert Thimme
Journal:  Semin Immunopathol       Date:  2018-11-29       Impact factor: 9.623

Review 5.  The impact of sex and age on T cell immunity and ischemic stroke outcomes.

Authors:  Hilda Ahnstedt; Louise D McCullough
Journal:  Cell Immunol       Date:  2019-08-01       Impact factor: 4.868

Review 6.  Do ribosomopathies explain some cases of common variable immunodeficiency?

Authors:  S Khan; J Pereira; P J Darbyshire; S Holding; P C Doré; W A C Sewell; A Huissoon
Journal:  Clin Exp Immunol       Date:  2010-11-09       Impact factor: 4.330

7.  Increased prevalence of autoimmunity in Turner syndrome--influence of age.

Authors:  K H Mortensen; L Cleemann; B E Hjerrild; E Nexo; H Locht; E M Jeppesen; C H Gravholt
Journal:  Clin Exp Immunol       Date:  2009-02-26       Impact factor: 4.330

Review 8.  Epigenetic Dysfunction in Turner Syndrome Immune Cells.

Authors:  Bradly J Thrasher; Lee Kyung Hong; Jason K Whitmire; Maureen A Su
Journal:  Curr Allergy Asthma Rep       Date:  2016-05       Impact factor: 4.806

9.  X-ring Turner's syndrome with combined immunodeficiency and selective gonadotropin defect.

Authors:  E Donti; I Nicoletti; G Venti; P Filipponi; R Gerli; F Spinozzi; C Cernetti; P Rambotti
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

10.  The role of X-linked FOXP3 in the autoimmune susceptibility of Turner Syndrome patients.

Authors:  Maureen A Su; Matthew Stenerson; Weihong Liu; Amy Putnam; Felix Conte; Jeffrey A Bluestone; Mark S Anderson
Journal:  Clin Immunol       Date:  2009-01-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.